fda compounding glp-1 Warns on Certain Forms of Compounded Semaglutide FDA regulators, customs officers, and

Many neuroprotective effects remain to be causally associated with anti-inflammatory mechanisms, and some Alzheimers disease mouse models did not respond to semaglutide or tirzepatide, emphasizing that not all neural benefits are consistent across studies

While fatigue on Ozempic may go away on its own for some, addressing hydration, sleep, and nutrient deficiencies should be addressed to effectively manage it, Dr

October 24th, 2025: New Study Links Ozempic to Potential Risk of Vision Loss A new study has identified a possible association between Ozempic and non-arteritic anterior ischemic optic neuropathy (NAION), a rare eye condition that can cause sudden and permanent vision loss

Consult with one of our licensed, medical providers through a text-based telehealth visit